A Case of Combination Therapy for Subretinal Neovascularization in Bilateral Acquired Parafoveal Telangiectasis
作者： Jeong-Wan Ryu , Jae-Ryun Kim , Won-Ki Lee
DOI: 10.3341/JKOS.2009.50.9.1423
关键词:
摘要: Purpose: To evaluate the clinical results of a case subretinal neovascularization (SRN) in bilateral acquired parafoveal telangiectasis, performed combination therapy intravitreal bevacizumab (1.25 mg/0.05ml) and photodynamic (PDT). Case summary: A 46-year-old female presented with decrease invisual acuity. Her best-corrected visual acuity (BCVA) was 1.0 right eye 0.1 left eye. On ophthalmic examination, she diagnosed telangiectasis combined SRN Intravitreal injected, then 4 days later. Three months after therapy, her BCVA improved to 0.5, regression observed vascular leakage markedly decreased. However, decreased recurred 9 Conclusions: The treatment may be used as selective alternative modality for although its effect is short-term.
koreascience.or.kr 参考文章(14)
Robert K. Hutchins, Vrinda S. Hershberger, Patrick W. Laber, Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis. Ophthalmic Surgery Lasers & Imaging. ,vol. 34, pp. 318- 320 ,(2003)
Suk J. Moon, Adam S. Berger, Michael J. Tolentino, David M. Misch, Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surgery Lasers & Imaging. ,vol. 38, pp. 164- 166 ,(2007) , 10.3928/15428877-20070301-15
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Archives of Ophthalmology. ,vol. 119, pp. 198- 207 ,(2001) , 10.1001/ARCHOPHT.117.10.1329
Maurizio Battaglia Parodi, Pierluigi Iacono, Giuseppe Ravalico, Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum Graefe's Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 612- 615 ,(2007) , 10.1007/S00417-006-0402-7
Bernadette Snyers, Claire Verougstraete, Laurence Postelmans, Anita Leys, Philip Hykin, Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis American Journal of Ophthalmology. ,vol. 137, pp. 812- 819 ,(2004) , 10.1016/J.AJO.2003.11.076
Lindsay M. Smithen, Richard F. Spaide, Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis American Journal of Ophthalmology. ,vol. 138, pp. 884- 885 ,(2004) , 10.1016/J.AJO.2004.05.073
Subrata Mandal, Pradeep Venkatesh, Zahir Abbas, Rajpal Vohra, Satpal Garg, Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 1825- 1829 ,(2007) , 10.1007/S00417-007-0567-8
Rodrigo Jorge, Rogério A. Costa, Daniela Calucci, Ingrid U. Scott, Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 1045- 1048 ,(2007) , 10.1007/S00417-006-0468-2
Nicholas E. Engelbrecht, Neovascular Membranes Associated With Idiopathic Juxtafoveolar Telangiectasis Archives of Ophthalmology. ,vol. 120, pp. 320- 324 ,(2002) , 10.1001/ARCHOPHT.120.3.320
Michael J Potter, Shelagh M Szabo, Eleanor Y Chan, Andrew H.C Morris, Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. American Journal of Ophthalmology. ,vol. 133, pp. 149- 151 ,(2002) , 10.1016/S0002-9394(01)01205-3